A citation-based method for searching scientific literature

Junko Murai, Shar-yin N Huang, Benu Brata Das, Amelie Renaud, Yiping Zhang, James H Doroshow, Jiuping Ji, Shunichi Takeda, Yves Pommier. Cancer Res 2012
Times Cited: 1099

Junko Murai, Ying Feng, Guoying K Yu, Yuanbin Ru, Sai-Wen Tang, Yuqiao Shen, Yves Pommier. Oncotarget 2016
Times Cited: 149

List of shared articles

Times cited

DNA repair defects in cancer and therapeutic opportunities.
Jessica L Hopkins, Li Lan, Lee Zou. Genes Dev 2022

Radiotherapy-Poly(ADP-ribose) Polymerase Inhibitor Combinations: Progress to Date.
Sarah J Derby, Anthony J Chalmers, Ross D Carruthers. Semin Radiat Oncol 2022

PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components.
Geraldine O'Sullivan Coyne, Chris Karlovich, Deborah Wilsker, Andrea Regier Voth, Ralph E Parchment, Alice P Chen, James H Doroshow. Onco Targets Ther 2022

PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites.
Xiaohui Lin, Wenxia Jiang, Johannes Rudolph, Brian J Lee, Karolin Luger, Shan Zha. Nucleic Acids Res 2022

Advances in Small-Cell Lung Cancer (SCLC) Translational Research.
Benjamin J Drapkin, Charles M Rudin. Cold Spring Harb Perspect Med 2021

The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage response.
Niamh Coleman, Bingnan Zhang, Lauren A Byers, Timothy A Yap. Br J Cancer 2021

Combination of talaporfin photodynamic therapy and Poly (ADP-Ribose) polymerase (PARP) inhibitor in gastric cancer.
Mamoru Tanaka, Makiko Sasaki, Taketo Suzuki, Hirotada Nishie, Hiromi Kataoka. Biochem Biophys Res Commun 2021